Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|1|14-26

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.1, 2015-01, pp. : 14-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucuronidation and Methylation of Procyanidin Dimers B2 and 3,3″-Di-O-Galloyl-B2 and Corresponding Monomers Epicatechin and 3-O-Galloyl-Epicatechin in Mouse Liver

By Shrestha Suraj   Thompson John   Wempe Michael   Gu Mallikarjuna   Agarwal Rajesh   Agarwal Chapla  

Pharmaceutical Research, Vol. 29, Iss. 3, 2012-03 ,pp. : 856-865

Springer Publishing Company

Access to resources Recommend Favorite

Troglitazone inhibits the capacitative Ca 2+ entry in endothelial cells

By Kawasaki J.   Hirano K.   Hirano M.   Nishimura J.   Fujishima M.   Kanaide H.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 111-120

Elsevier

Access to resources Recommend Favorite

Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN

By  

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-01 ,pp. : 2237-2244

Bentham Science Publishers

Access to resources Recommend Favorite

Efficient siRNA Delivery Using PEG-conjugated PAMAM Dendrimers Targeting Vascular Endothelial Growth Factor in a CoCl2-induced Neovascularization Model in Retinal Endothelial Cells

By  

Current Drug Delivery, Vol. 13, Iss. 4, 2016-06 ,pp. : 590-599

Bentham Science Publishers

Access to resources Recommend Favorite

Grb2 signaling in cell motility and cancer

By Giubellino Alessio   Burke Terrence R   Bottaro Donald P  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1021-1033

Informa Healthcare

Access to resources Recommend Favorite